论文部分内容阅读
利用国内有关医药数据库,检索和下载关键词“头孢呋辛”“痰热清”和两药联用治疗肺炎、小儿支气管肺炎、社区获得性肺炎、急性上呼吸道感染、支气管炎、小儿扁桃体炎和慢性阻塞性肺疾病等呼吸系统感染性疾病的临床治疗的研究文献,介绍头孢呋辛与痰热清联用治疗呼吸系统感染性疾病患者临床治疗的研究概况。采用头孢呋辛与痰热清联用治疗肺炎、小儿支气管肺炎、社区获得性肺炎、急性上呼吸道感染、支气管炎、小儿扁桃体炎和慢性阻塞性肺疾病等疾病临床治疗的总有效率均在90%以上,并且不良反应的发生率较低。综述头孢呋辛与痰热清联用治疗呼吸系统感染性疾病患者的临床治疗的文献,并对其研究进展作了分析。
Use of the relevant national medical database, search and download key words “cefuroxime” “Tanreqing” and two drugs combined treatment of pneumonia, bronchial pneumonia in children, community-acquired pneumonia, acute upper respiratory tract infection, bronchitis, Pediatric tonsillitis and chronic obstructive pulmonary disease and other respiratory diseases such as clinical treatment of the literature, describes the cefuroxime and Tanreqing combined with the treatment of respiratory infections in patients with clinical research. The total effective rate of clinical treatment of diseases such as pneumonia, pediatric bronchopneumonia, community-acquired pneumonia, acute upper respiratory tract infection, bronchitis, pediatric tonsillitis and chronic obstructive pulmonary disease by using cefuroxime and phlegm-heat combined therapy is 90 % Or more, and the incidence of adverse reactions is low. The literature about the clinical treatment of patients with respiratory diseases with cefuroxime and Tanreqing combined with anti-infective diseases is reviewed. The progress of the study is also analyzed.